Frequently Asked Questions about Johnson & Johnson (JNJ)

Name: Johnson & Johnson (JNJ) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Johnson & Johnson (JNJ) do?

Accepted Answer

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the for...

Question 2

Is Johnson & Johnson (JNJ) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of JNJ reveals an Altman Z-Score of 5.17 and a Piotroski F-Score of 4/9. These metrics, combined with its 5-year revenue trend ($94.19B most recent), help investors decide if JNJ fits their risk profile.

Question 3

What is the current P/E ratio for JNJ?

Accepted Answer

As of the latest trading session, Johnson & Johnson (JNJ) has a trailing P/E ratio of 21.86.

Question 4

Who is the CEO of Johnson & Johnson?

Accepted Answer

The current Chief Executive Officer of Johnson & Johnson is Joaquin Duato.

Question 5

What was JNJ's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Johnson & Johnson reported annual revenues of $94.19B (2025), $88.82B (2024), $85.16B (2023), $79.99B (2023), $78.74B (2022) respectively.

Question 6

Does JNJ pay a dividend?

Accepted Answer

Johnson & Johnson currently pays a dividend to its shareholders, with a trailing dividend yield of 2.15%.

Question 7

How much debt and cash flow does JNJ have?

Accepted Answer

In its latest reporting period, Johnson & Johnson generated $19.70B in Free Cash Flow against a total debt load of $47.93B.

Question 8

What is the Price-to-Book (P/B) ratio of Johnson & Johnson?

Accepted Answer

The Price-to-Book (P/B) ratio for Johnson & Johnson (JNJ) is currently 7.19.

Question 9

What is the Price-to-Sales (P/S) ratio of JNJ?

Accepted Answer

Based on trailing twelve-month data, Johnson & Johnson (JNJ) trades at a Price-to-Sales (P/S) ratio of 6.17.

Question 10

What is Johnson & Johnson's Return on Equity (ROE)?

Accepted Answer

Johnson & Johnson (JNJ) has a Return on Equity (ROE) of 33.78%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	24.5B	1.4B	-4.8B	19.7B	18.3B
2024-12	24.3B	1.2B	-4.4B	19.8B	18.7B
2023-12	22.8B	1.2B	-4.5B	18.2B	17.1B
2023-01	21.2B	1.1B	-4B	17.2B	16B
2022-01	23.4B	1.1B	-3.7B	19.8B	18.6B

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	24.5B	1.4B	-4.8B	19.7B	18.3B
2024-12	24.3B	1.2B	-4.4B	19.8B	18.7B
2023-12	22.8B	1.2B	-4.5B	18.2B	17.1B
2023-01	21.2B	1.1B	-4B	17.2B	16B
2022-01	23.4B	1.1B	-3.7B	19.8B	18.6B